About the journal
Asia-Pacific Journal of Clinical Oncology is a journal published by Wiley in Australia. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,350 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 1743-7555 · 1743-7563
- Country
- Australia
- Access
- Not open access / not declared
- Declared publication charge
- 3,350 USD
- Declared peer-review model
- peer_review
- Official website
- https://onlinelibrary.wiley.com/journal/17437563
Index listings
- MEDLINE · 2009-01-01
- Indexing
- MEDLINE
- APC
- 3,350 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 147 days received→accepted — computed from PubMed (n=93)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
3311
Last recorded publication year
2026
h-index
55
i10-index
655
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 76%
- ORCID iDs in current deposits
- 38%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity4
- Alternate titles
- Clinical oncology
- Source type
- journal
- NLM unique ID (PubMed)
- 101241430
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Multiple and Secondary Primary Cancers
- Multiple and Secondary Primary Cancers
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
Show all subjects (50)
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Advances in Oncology and Radiotherapy
- Advances in Oncology and Radiotherapy
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- Global Cancer Incidence and Screening
- Colorectal Cancer Treatments and Studies
- Educational Robotics and Engineering
- Educational Robotics and Engineering
- Cancer survivorship and care
- Lung Cancer Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- Global Cancer Incidence and Screening
- Cancer Treatment and Pharmacology
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Prostate Cancer Treatment and Research
- Health Systems, Economic Evaluations, Quality of Life
- Hepatocellular Carcinoma Treatment and Prognosis
- Head and Neck Cancer Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Head and Neck Cancer Studies
- Health Systems, Economic Evaluations, Quality of Life
- Cancer Genomics and Diagnostics
- Gastric Cancer Management and Outcomes
- Prostate Cancer Treatment and Research
- Cancer Genomics and Diagnostics
- Clinical practice guidelines implementation
- Gastric Cancer Management and Outcomes
- Clinical practice guidelines implementation
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Surgical Treatments
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ